The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study

References

• MaddockRJBuonocoreMHMR spectroscopic studies of the brain in psychiatric disordersCurr Top Behav Neurosci Epub201221
   Google Scholar
• MoffettJRRossBArunPMadhavaraoCNNamboodiriAMN-acetylaspartate in the CNS: from neurodiagnostics to neurobiologyProg Neurobiol20078128913117275978
   PubMed Web of Science ®Google Scholar
• DemougeotCMarieCGiroudMBeleyAN-acetylaspartate: a literature review of animal research on brain ischaemiaJ Neurochem200490477678315287882
   PubMed Web of Science ®Google Scholar
• NarayananSDe StefanoNFrancisGSAxonal metabolic recovery in multiple sclerosis patients treated with interferon β-1bJ Neurol20012481197998611757963
   PubMed Web of Science ®Google Scholar
• SaloRBuonocoreMHLeamonMExtended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: a proton MRS studyDrug Alcohol Depend20111132–313313820739127
   PubMed Web of Science ®Google Scholar
• HenigsbergNKalemberPHrabaćP1-H MRS changes in dorsolateral prefrontal cortex after donepezil treatment in patients with mild to moderate Alzheimer’s diseaseColl Antropol201135Suppl 115916221648328
   PubMedGoogle Scholar
• HenigsbergNBajsMHrabaćPChanges in brain metabolites measured with magnetic resonance spectroscopy in antidepressant responders with comorbid major depression and posttraumatic stress disorderColl Antropol201135Suppl 114514821648325
   PubMedGoogle Scholar
• SteenRGMullCMcClureRHamerRMLiebermanJABrain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studiesBr J Psychiatry200618851051816738340
   PubMed Web of Science ®Google Scholar
• FannonDSimmonsATennakoonLSelective deficit of hippocampal N-acetylaspartate in antipsychotic-naïve patients with schizophreniaBiol Psychiatry200354658759813129653
   PubMed Web of Science ®Google Scholar
• BustilloJRRowlandLMJungRProton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophreniaNeuropsychopharmacology200833102456246618094668
   PubMed Web of Science ®Google Scholar
• LiebermanJATollefsonGDCharlesCAntipsychotic drug effects on brain morphology in first-episode psychosisArch Gen Psychiatry200562436137015809403
   PubMed Web of Science ®Google Scholar
• LindquistDMHawkRMKarsonCNKomoroskiRAEffects of antipsychotic drugs on metabolite ratios in rat brain in vivoMagn Reson Med200043335535810725877
   PubMed Web of Science ®Google Scholar
• BustilloJWolffCMyers-y-GutierrezATreatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levelsSchizophr Res2004661313914693350
   PubMed Web of Science ®Google Scholar
• HarteMKBachusSBReynoldsGPIncreased N-acetylaspartate in rat striatum following long-term administration of haloperidolSchizophr Res2005752–330330815885521
   PubMed Web of Science ®Google Scholar
• McLoughlinGAMaDTsangTMAnalyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopyJ Proteome Res2009841943195219714815
   PubMed Web of Science ®Google Scholar
• BustilloJBarrowRPazRLong-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levelsNeuropsychopharmacology200631475175616132064
   PubMed Web of Science ®Google Scholar
• LindquistDMDunnRSCecilKMLong term antipsychotic treatment does not alter metabolite concentrations in rat striatum: an in vivo magnetic resonance spectroscopy studySchizophr Res20111281–3839021429713
   PubMed Web of Science ®Google Scholar
• BertolinoACallicottJHMattayVSThe effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophreniaBiol Psychiatry2001491394611163778
   PubMed Web of Science ®Google Scholar
• BustilloJRRowlandLMMullinsP1H-MRS at 4 Tesla in minimally treated early schizophreniaMol Psychiatry201015662963619918243
   PubMed Web of Science ®Google Scholar
• BrausDFEndeGWeber-FahrWDemirakcaTTostHHennFAFunctioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophreniaEur Neuropsychopharmacol200212214515211872332
   PubMed Web of Science ®Google Scholar
• BustilloJRLaurielloJRowlandLMEffects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophreniaPsychiatry Res2001107313514911566430
   PubMed Web of Science ®Google Scholar
• SzulcAGalinskaBTarasowEN-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) studyMed Sci Monit200713Suppl 1172217507880
   PubMedGoogle Scholar
• YeoRAHillDCampbellRVigilJBrooksWMDevelopmental instability and working memory ability in children: a magnetic resonance spectroscopy investigationDev Neuropsychol200017214315910955200
   PubMed Web of Science ®Google Scholar
• ValenzuelaMJSachdevPSWenWShnierRBrodatyHGilliesDDual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changesNeuroimage200012674775611112406
   PubMed Web of Science ®Google Scholar
• BertolinoASciotaDBrudaglioFWorking memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorderAm J Psychiatry2003160348348912611829
   PubMed Web of Science ®Google Scholar
• BertolinoAEspositoGCallicottJHSpecific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophreniaAm J Psychiatry20001571263310618009
   PubMed Web of Science ®Google Scholar
• TanakaYObataTSassaTQuantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunctionPsychiatry Clin Neurosci200660336537216732755
   PubMed Web of Science ®Google Scholar
• BrackenBKRouseEDRenshawPFOlsonDPT2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophreniaPsychiatry Res2013213214215323769421
   PubMed Web of Science ®Google Scholar
• ReidMAKraguljacNVAvsarKBWhiteDMden HollanderJALahtiACProton magnetic resonance spectroscopy of the substantia nigra in schizophreniaSchizophr Res20131472–334835423706412
   PubMed Web of Science ®Google Scholar
• SzulcAGalińska-SkokBWaszkiewiczNBibulowiczDKonarzewskaBTarasówEProton magnetic resonance spectroscopy changes after antipsychotic treatmentCurr Med Chem201320341442723157634
   PubMed Web of Science ®Google Scholar
• SzulcAGalińska-SkokBTarasówEClinical and cognitive correlates of the proton magnetic resonance spectroscopy measures in chronic schizophreniaMed Sci Monit2012186CR390CR39822648255
   PubMed Web of Science ®Google Scholar
• FirstMBSpitzerRLGibbonMWiliamsJBWStructured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version (SCID-I)New York, NYBiometrics Research2001
   Google Scholar
• PosnerKBrownGKStanleyBThe Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adultsAm J Psychiatry2011168121266127722193671
   PubMed Web of Science ®Google Scholar
• KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull19871322612763616518
   PubMed Web of Science ®Google Scholar
• GuyWECDEU Assessment Manual for PsychopharmacologyWashington, DCUS Department of Health, Education, and Welfare1976
   Google Scholar
• CulbertsonWZillmerETower of London Drexel University (TOL DX)2nd edChicago, ILMulti-Health Systems2005
   Google Scholar
• TombaughTNTrail Making Test A and B: normative data stratified by age and educationArch Clin Neuropsychol200419220321415010086
   PubMed Web of Science ®Google Scholar
• GoldJMCarpenterCRandolphCGoldbergTEWeinbergerDRAuditory working memory and Wisconsin Card Sorting Test performance in schizophreniaArch Gen Psychiatry19975421591659040284
   PubMed Web of Science ®Google Scholar
• MorosiniPLMaglianoLBrambillaLUgoriniSPioliRDevelopment, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioningActa Psychiatr Scand2000101432332910782554
   PubMed Web of Science ®Google Scholar
• SimpsonGMAngusJWA rating scale for extrapyramidal side effectsActa Psychiatr Scand Suppl197021211194917967
   PubMedGoogle Scholar
• SimpsonGMLeeJHZoubokBGardosGA rating scale for tardive dyskinesiaPsychopharmacology (Berl)1979642171179115037
   PubMed Web of Science ®Google Scholar
• BarnesTRA rating scale for drug-induced akathisiaBr J Psychiatry19891546726762574607
   PubMed Web of Science ®Google Scholar
• DelBelloMPCecilKMAdlerCMDanielsJPStrakowskiSMNeurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy studyNeuropsychopharmacology20063161264127316292323
   PubMed Web of Science ®Google Scholar
• KalayciDOzdelOSözeri-VarmaGKiroğluYTümkayaSA proton magnetic resonance spectroscopy study in schizoaffective disorder: comparison of bipolar disorder and schizophreniaProg Neuropsychopharmacol Biol Psychiatry201237117618122306485
   PubMed Web of Science ®Google Scholar
• RossAJSachdevPSMagnetic resonance spectroscopy in cognitive researchBrain Res Brain Res Rev2004442–38310215003387
   PubMedGoogle Scholar
• BustilloJRChenHGasparovicCGlutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 TeslaBiol Psychiatry2011691192720970118
   PubMed Web of Science ®Google Scholar
• TandonNBoloNRSanghaviKBrain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopySchizophr Res20131481–3596623791389
   PubMed Web of Science ®Google Scholar
• BustilloJRUse of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical updateDialogues Clin Neurosci201315332933724174904
   PubMedGoogle Scholar